|Min SIP Amount||Not Supported|
|NAV||₹8.85 (19 Jan 2021)|
|Fund Started||06 Apr 2018|
|Fund Size||₹105 Cr|
|Bandhan Bank Ltd.||Financial||Equity||7.6%|
|Mahindra & Mahindra Financial Services Ltd.||Financial||Equity||5.7%|
|Mahindra & Mahindra Ltd.||Automobile||Equity||5.1%|
|Hero Motocorp Ltd.||Automobile||Equity||4.4%|
|Strides Pharma Science Ltd.||Healthcare||Equity||3.8%|
|Aster DM Healthcare Ltd.||Healthcare||Equity||3.7%|
|Tata Consumer Products Ltd.||FMCG||Equity||3.7%|
Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 06 Apr 2018. Satyabrata Mohanty, Milind Bafna is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹105 Cr and the Latest NAV as of 19 Jan 2021 is ₹8.85.
The Aditya Birla Sun Life Resurgent India Fund Series 7 Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The scheme seeks to provide capital appreciation by investing primarily in equity and equity related securities that are likely to benefit from recovery in the Indian economy.